Intensive Glycemic Management and Outcomes Following Liver Transplantation

Completed · Not applicable

Conditions studied: Hospital Hyperglycemia, Post-transplant Hyperglycemia

In brief

Most people develop high blood sugars following liver transplant that requires treatment with insulin in the hospital, even if they don't have diabetes, due to stress and use of steroid medications. High blood sugar levels can be treated with a hormone that the body makes called insulin. This study is being done to determine if maintaining normal blood sugar levels after transplant for as long as needed while in the hospital results in a lesser incidence of death, infections, transplanted liver rejection or failure or need for rehospitalization within 90 days after transplant.

Key facts

Study ID

NCT01432093

Run by

Mayo Clinic

People needed

270

Starts

2011-10-01

Expected to finish

2013-07-01

Last updated by the study team

2013-11-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age and older
• Undergoing liver transplant or combined liver-kidney transplant

You may not qualify if…

• Unable to grant informed consent or comply with study procedure
• Allergic to any of the excipients in insulin

Where it is running

• Mayo Clinic — Jacksonville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.